• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

WNK Kinases Regulate RNF43 Cell Surface Levels to Modulate WNT Signaling

by
November 10, 2026
in Health
Reading Time: 5 mins read
0
WNK Kinases Regulate RNF43 Cell Surface Levels to Modulate WNT Signaling

WNK Kinases Regulate RNF43 Cell Surface Levels to Modulate WNT Signaling

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Canonical WNT signaling governs tissue homeostasis, stem cell renewal, and embryonic patterning, but its hyperactivation frequently drives the initiation and progression of human malignancies, most notably colorectal cancers. To prevent uncontrolled pathway stimulation, cells deploy the transmembrane E3 ubiquitin ligases RNF43 and ZNRF3, which trigger the endolysosomal degradation of the primary WNT receptors Frizzled and LRP5/6. While the receptor-clearing role of these ligases has been documented extensively, the cellular machinery governing the spatial localization and membrane abundance of RNF43 and ZNRF3 has remained poorly understood. The newly reported findings establish that WNK kinases control RNF43 trafficking and ubiquitination, providing an upstream mechanism that fine-tunes receptor availability at the cell surface.

To systematically map the protein interactome of RNF43 across distinct cellular compartments, the researchers designed a complementary dual-proximity biotinylation strategy in human embryonic kidney cells. They engineered two separate inducible fusion constructs: one attaching the engineered ascorbate peroxidase APEX2 to the carboxy-terminal cytoplasmic tail of RNF43 to capture intracellular binding partners, and a second placing horseradish peroxidase immediately following the amino-terminal signal peptide within the extracellular domain to label cell-surface and extracellular interactors. Following doxycycline induction and biotin-phenol labeling in stable HEK293T-REx lines, affinity-purified proteins were subjected to quantitative mass spectrometry. Intracellular APEX2 tagging significantly enriched 183 proteins, capturing cytosolic kinases, endoplasmic reticulum and Golgi components, and endocytic trafficking machinery, including the cytosolic serine-threonine kinase WNK1. In contrast, extracellular peroxidase labeling enriched 577 proteins, predominantly recovering transmembrane receptors, known pathway partners such as LRP6, PTK7, and ROR1/2, and the sorting receptor SORTILIN.

Subsequent biochemical experiments confirmed physical interactions between RNF43 and endogenous WNK1 as well as transfected WNK2. WNK kinases are a distinct evolutionary family of serine and threonine kinases known for an atypical catalytic lysine placement within their kinase domain. Classically studied as osmosensory regulators of ion homeostasis and renal cotransporter trafficking, WNK family members had previously been linked to tumor growth and Dishevelled phosphorylation, yet their specific involvement in mammalian WNT receptor dynamics had not been resolved. Co-immunoprecipitation assays demonstrated that RNF43 complexes with WNK1 and WNK2 in mammalian cell lysates, and these interactions persisted even in the presence of pathway agonists such as R-spondin proteins, suggesting a stable regulatory connection between the kinase family and the ubiquitin ligase.

Functional evaluation using TOPFlash luciferase reporter assays and Western blotting demonstrated that WNK family members actively participate in calibrating canonical WNT output. Overexpression of wild-type WNK2 in HEK293T cells significantly elevated reporter activity in a ligand-dependent manner, an effect completely abrogated by the Porcupine inhibitor IWP2, which blocks endogenous WNT ligand secretion. A kinase-dead mutant, WNK2 carrying a K207A substitution, failed to stimulate pathway activation, whereas a constitutively active variant bearing an S356E substitution amplified signaling beyond wild-type levels. Conversely, pharmacological inhibition of WNK catalytic activity using the small-molecule inhibitor STOCK2S-26016 potently suppressed WNT3A-induced reporter expression and reduced intracellular levels of unphosphorylated, transcriptionally active beta-catenin in wild-type cells.

Epistasis experiments positioned WNK kinase activity upstream of the beta-catenin destruction complex and demonstrated a direct dependency on functional RNF43 and ZNRF3 ligases. While the WNK inhibitor suppressed signaling driven by exogenous WNT ligands, it failed to blunt reporter activation provoked by direct beta-catenin overexpression or downstream GSK3 inhibition. Crucially, in RNF43 and ZNRF3 double-knockout cells or cells expressing a dominant-negative RNF43 mutant lacking its catalytic RING domain, pharmacological WNK inhibition caused no reduction in active beta-catenin levels. Phosphoproteomic mass spectrometry profiling revealed no detectable change in RNF43-specific phosphopeptides upon WNK1 co-expression or inhibitor administration, indicating that WNK kinases do not directly phosphorylate the ligase but rather influence its function through indirect trafficking and post-translational cascades.

To clarify how WNK activity influences RNF43 localization, the authors monitored the cell surface pool of the ligase using SNAP-tag pulse-chase labeling, immunofluorescence confocal microscopy, and quantitative HiBiT nanoluciferase assays. Pharmacological WNK inhibition produced an approximately 30 percent increase in HiBiT-RNF43 surface levels on HEK293T cells, with corresponding increases observed for ZNRF3. Confocal analysis confirmed enhanced colocalization of tagged RNF43 with the plasma membrane marker Desmoglein-2 upon inhibitor treatment. Concordantly, elevating cell surface RNF43 via WNK inhibition accelerated the endocytosis and degradation of its target receptors: HiBiT assays showed a significant decrease in surface FZD5, while live-cell holotomographic imaging demonstrated that WNK inhibition dramatically accelerated the clearance of WNT3A-bound SNAP-FZD5 from the plasma membrane within 15 minutes of stimulation.

Biochemical assays focused on ubiquitin linkage specificity provided a molecular mechanism explaining the altered membrane distribution of the ligase. Overexpression of WNK2 selectively augmented K63-linked polyubiquitination of RNF43 without altering K48-linked polyubiquitination. In contrast, treating cells with the small-molecule WNK inhibitor markedly reduced K63-linked ubiquitination on RNF43 while leaving total ligase abundance largely intact. Because K63-linked chains frequently regulate the internalization, recycling, and endosomal routing of transmembrane proteins, these data indicate that WNK signaling promotes the internalization and intracellular retention of RNF43 away from the plasma membrane, whereas suppressing WNK catalytic activity stabilizes RNF43 at the cell surface to execute receptor turnover.

The physiological importance of the WNK-RNF43 axis was verified in mouse small intestinal organoid models, where canonical WNT signaling is indispensable for maintaining stem cell self-renewal within the epithelial crypt niche. Treating wild-type intestinal organoids with the WNK inhibitors STOCK2S-26016 or the structurally distinct pan-WNK inhibitor WNK463 resulted in severe, dose-dependent growth arrest and morphological collapse, displaying phenotypes comparable to the Porcupine inhibitor IWP2. Immunofluorescence staining of treated organoids confirmed widespread losses of nuclear active beta-catenin and the WNT-dependent stem cell marker CD44. Consistent with cell line epistasis, intestinal organoids derived from RNF43 and ZNRF3 double-knockout mice or APC-deficient mice were completely resistant to WNK inhibition, confirming that WNK inhibitors require an intact receptor clearance module to repress tissue growth.

Finally, the authors evaluated the therapeutic utility of WNK inhibition in oncogenic contexts driven by aberrant WNT pathway activation. They established intestinal organoids harboring a PTPRK-RSPO3 chromosomal fusion, a genetic alteration identified in human colorectal carcinomas that produces autonomous RSPO3 expression, thereby sequestering RNF43 and ZNRF3 away from Frizzled receptors to amplify WNT signaling. While wild-type organoids perish upon withdrawal of exogenous RSPO1 from culture media, PTPRK-RSPO3 fusion organoids sustained continuous growth under ligand-deprived conditions. Administration of the WNK inhibitor STOCK2S-26016 eliminated these fusion-driven cystic organoids, demonstrating that pharmacological inhibition of WNK can restore pathway suppression in tumors dependent on upstream WNT ligand interactions.

The study also demonstrated that WNK inhibition can partially rescue the trafficking defects of specific oncogenic RNF43 mutations. The non-functional mutant RNF43 I48T, which was reported to accumulate within the endoplasmic reticulum, normally fails to clear surface Frizzled receptors. Treatment with WNK inhibitor restored detectable cell surface expression of RNF43 I48T in HiBiT assays and significantly improved its capacity to internalize SNAP-tagged FZD5 and suppress TOPFlash reporter activity. Collectively, these findings establish WNK family kinases as key regulators of RNF43 trafficking and membrane availability, highlighting WNK inhibition as a promising therapeutic strategy to re-establish pathway control in WNT-dependent malignancies harboring RSPO fusions or trafficking-deficient RNF43 variants.

Subject of Research: Regulation of WNT signaling receptor turnover and RNF43 trafficking by WNK kinases

Article Title: WNK kinases control RNF43 plasma membrane levels to fine-tune WNT signaling

Article References: Seo, D. W., Sosa, E., Jordens, I., Ha, J., Wu, S.-H. S., Tavernini, K., Català-Bordes, A., Farnhammer, F., Urbán, N., Maurice, M. M., Lee, S., Kim, J., Koo, B.-K., & Colozza, G. (2026). WNK kinases control RNF43 plasma membrane levels to fine-tune WNT signaling. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-026-01871-4

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01871-4

Keywords: WNT signaling, RNF43, WNK kinases, proteomics, organoids, colorectal cancer, ubiquitination, cell biology, kinases, control, plasma, membrane

News Source: Ophelia Keating. (November 10, 2026). WNK Kinases Regulate RNF43 Cell Surface Levels to Modulate WNT Signaling. Scienmag.

Tags: Cell BiologyColorectal cancercontrolkinasesmembraneorganoidsplasmaProteomicsRNF43UbiquitinationWNK kinasesWnt Signaling
Share12Tweet7Share2ShareShareShare1

Related Posts

Dynamic Cognitive Models Improve External Dementia Transition Predictions But Face Major Limits

Dynamic Cognitive Models Improve External Dementia Transition Predictions But Face Major Limits

November 16, 2026
Review finds two thirds of pediatric glioneuronal tumor cases initially misdiagnosed

Review finds two thirds of pediatric glioneuronal tumor cases initially misdiagnosed

November 16, 2026

Conflict-Era Maternal Age Linked to Adult Stature Differences in Timor-Leste

November 16, 2026

First-Time Blood Donors Overestimate Pain and Dizziness in Swiss Study

November 16, 2026

POPULAR NEWS

  • Attention Graph Model Improves Dynamic Anomaly Detection Across Six Datasets

    Attention Graph Model Improves Dynamic Anomaly Detection Across Six Datasets

    29 shares
    Share 12 Tweet 7
  • Blockchain-Integrated Machine Learning Enhances Fraud Detection in Supply Chain Networks

    29 shares
    Share 12 Tweet 7
  • Dynamic Cognitive Models Improve External Dementia Transition Predictions But Face Major Limits

    29 shares
    Share 12 Tweet 7
  • Binary Hippopotamus Optimization Achieves High Accuracy Across Sixteen Cancer Datasets

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Adaptive Cognitive Honeynet Improves Cybersecurity Deception Across Industrial Internet of Things Networks

FFLE-Net Improves Small Object Detection in Remote Sensing Across Aerial Datasets

Adaptive Sharding Mechanism Boosts Blockchain Transaction Throughput for Mobile Edge Computing

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.